Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience

References

Page 1

	Year	Citations
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data Jean Bourhis, C. Domenge, L. Designé The Lancet Neoadjuvant TherapyMedicineLocoregional TreatmentPathologyNeck Squamous-cell Carcinoma	2000	2.5K
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer David J. Adelstein, Yi Li, George L. Adams, Journal of Clinical Oncology	2002	1.7K
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 Karen K. Fu, Thomas F. Pajak, Andy Trotti, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineAccelerated FractionationRadiation TherapyFractionation RadiotherapyMedicine	2000	1.4K
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma G. Calais, M. Alfonsi, É. Bardet, JNCI Journal of the National Cancer Institute	1999	1.1K
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Nancy Lee, Ping Xia, Jeanne M. Quivey, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation TherapyMedicineNasopharyngeal CancerIntensity-modulated Radiotherapy	2002	986
Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx Carcinoma Fabrice Denis, P. Garaud, É. Bardet, Journal of Clinical Oncology	2003	888
Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer David M. Brizel, Todd H. Wasserman, Michael Henke, Journal of Clinical Oncology	2000	830
Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer Avraham Eisbruch, Hyungjin Myra Kim, Jeffrey E. Terrell, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicineHead And Neck CancerNeck OncologyOncology	2001	766
A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results K. S. Clifford Chao, Joseph O. Deasy, Jerry Markman, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicineThree-dimensional Radiation TherapySalivary FunctionHead And Neck Cancer	2001	597
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data Jean‐Pierre Pignon The Lancet Neoadjuvant TherapyMedicineLocoregional TreatmentPathologyNeck Squamous-cell Carcinoma	2000	566

Page 1